Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$15.45 - $26.02 $150,637 - $253,695
9,750 Added 12.12%
90,200 $1.53 Million
Q3 2022

Nov 02, 2022

SELL
$15.42 - $27.01 $12,536 - $21,959
-813 Reduced 1.0%
80,450 $1.83 Million
Q2 2022

Aug 01, 2022

BUY
$13.27 - $25.5 $940,829 - $1.81 Million
70,899 Added 684.09%
81,263 $1.47 Million
Q1 2022

May 04, 2022

SELL
$13.42 - $29.73 $285,134 - $631,673
-21,247 Reduced 67.21%
10,364 $173,000
Q4 2021

Feb 07, 2022

SELL
$27.59 - $66.39 $69,747 - $167,833
-2,528 Reduced 7.41%
31,611 $927,000
Q3 2021

Nov 02, 2021

SELL
$65.76 - $90.65 $221,545 - $305,399
-3,369 Reduced 8.98%
34,139 $2.25 Million
Q2 2021

Aug 03, 2021

SELL
$57.98 - $96.6 $133,527 - $222,469
-2,303 Reduced 5.78%
37,508 $3.12 Million
Q1 2021

May 04, 2021

BUY
$71.56 - $121.23 $565,109 - $957,353
7,897 Added 24.74%
39,811 $3.05 Million
Q4 2020

Feb 01, 2021

BUY
$47.41 - $115.03 $849,444 - $2.06 Million
17,917 Added 128.01%
31,914 $2.82 Million
Q3 2020

Nov 09, 2020

BUY
$43.0 - $84.01 $601,871 - $1.18 Million
13,997 New
13,997 $1.03 Million
Q2 2020

Aug 07, 2020

SELL
$51.3 - $75.21 $62,432 - $91,530
-1,217 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$31.51 - $73.75 $77,892 - $182,310
-2,472 Reduced 67.01%
1,217 $68,000
Q4 2019

Feb 06, 2020

BUY
$17.25 - $49.51 $42,176 - $121,051
2,445 Added 196.54%
3,689 $141,000
Q4 2019

Feb 04, 2020

BUY
$17.25 - $49.51 $21,459 - $61,590
1,244 New
1,244 $42,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.